Parkinson’s disease is a neurodegenerative disorder, leading to progressive degeneration of motor functions of the patients due to death of dopamine-producing brain cells.Early in the disease, the most obvious symptoms are shaking, rigidity, slowness of movement, and difficulty with walking. Thinking and behavioral problems may also occur.Dementia becomes common in the advanced stages of the disease.Depression and anxiety are also common occurring in more than a third of people with PD. Other symptoms include sensory, sleep, and emotional problems. The main motor symptoms are collectively called “parkinsonism”, or a “parkinsonian syndrome”. Patients’ voice tends to stutter and progressively becomes affected as the disease becomes more severe.The motor symptoms of the disease result from the death of cells in the substantia nigra, a region of the midbrain. This results in not enough dopamine in these areas.The reason for this cell death is poorly understood, but involves the build-up of proteins into Lewy bodies in the neurons.There is no cure for Parkinson’s disease, with treatment directed at improving symptoms. Treatment usually begins with the antiparkinson medication levodopa (L-DOPA). As the disease progresses and neurons continue to be lost, the medications lose their effectiveness. Moreover, they tend to produce a complication marked by involuntary writhing movements. Diet and some forms of rehabilitation have shown some effectiveness at improving symptoms.Placing microelectrodes by use of surgery for deep brain stimulation has been used to lessen symptoms related to motor abilities in cases where drugs are ineffective.The organisation of our paper is as follows: First, we explain the objective of our research followed by discussing the related previous works in this field. Then, we describe our proposed methodology and the experimentation work. Finally, we conclude with accuracy and data analysis results and future scope of our research which could further better the output.